Table of Contents
Minireviews
- Journal Article | Research Support, U.S. Gov't, P.H.S. | ReviewInsights into erythromycin action from studies of its activity as inducer of resistance.
Articles
- Journal Article | Research Support, Non-U.S. Gov'tTarget for bacteriostatic and bactericidal activities of beta-lactam antibiotics against Escherichia coli resides in different penicillin-binding proteins.
- Journal Article | Research Support, Non-U.S. Gov't | Research Support, U.S. Gov't, Non-P.H.S.Increasing antimicrobial resistance of Shigella isolates in Israel during the period 1984 to 1992.
- Journal Article | Research Support, Non-U.S. Gov'tPlasmid-mediated dissemination of the metallo-beta-lactamase gene blaIMP among clinically isolated strains of Serratia marcescens.
- Journal Article | Research Support, Non-U.S. Gov'tInducible and constitutive expression of resistance to glycopeptides and vancomycin dependence in glycopeptide-resistant Enterococcus avium.
- Journal Article | Research Support, Non-U.S. Gov'tTolerability, kinetics, and efficacy of subconjunctival pefloxacin in pigmented rabbits.
- Journal Article | Research Support, U.S. Gov't, P.H.S.Quantitation of slow drug release from an implantable and degradable gentamicin conjugate by in vivo magnetic resonance imaging.
- Journal Article | Research Support, Non-U.S. Gov'tAntiviral effect of oryzacystatin, a proteinase inhibitor in rice, against herpes simplex virus type 1 in vitro and in vivo.
- Journal Article | Research Support, Non-U.S. Gov'tIn vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent.
- Journal Article | Research Support, U.S. Gov't, Non-P.H.S. | Research Support, U.S. Gov't, P.H.S.Evaluation of maduramicin and alborixin in a SCID mouse model of chronic cryptosporidiosis.
- Comparative Study | Journal Article | Research Support, Non-U.S. Gov'tIn vitro activity of D0870 compared with those of other azoles against fluconazole-resistant Candida spp.
- Journal Article | Research Support, Non-U.S. Gov'tPrimary structure of OXA-3 and phylogeny of oxacillin-hydrolyzing class D beta-lactamases.
- Journal Article | Research Support, Non-U.S. Gov'tChlorhexidine susceptibilities of mutans streptococcal serotypes and ribotypes.
- Journal Article | Research Support, Non-U.S. Gov'tSHV-7, a novel cefotaxime-hydrolyzing beta-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients.
- Journal Article | Research Support, U.S. Gov't, P.H.S.Trends in susceptibility of Neisseria gonorrhoeae to ceftriaxone from 1985 through 1991.
- Journal Article | Research Support, Non-U.S. Gov'tEffect of testing method on apparent activities of antiviral disinfectants and antiseptics.
- Comparative Study | Journal Article | Research Support, Non-U.S. Gov'tComparison of ampicillin-sulbactam regimens simulating 1.5- and 3.0-gram doses to humans in treatment of Escherichia coli bacteremia in mice.
- Clinical Trial | Comparative Study | Journal Article | Randomized Controlled Trial | Research Support, Non-U.S. Gov'tProspective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children.
- Journal Article | Meta-Analysis | Research Support, Non-U.S. Gov'tProphylaxis with enteral antibiotics in ventilated patients: selective decontamination or selective cross-infection?
- Journal Article | Research Support, Non-U.S. Gov'tIn vitro activities of novel antifolate drug combinations against Plasmodium falciparum and human granulocyte CFUs.
- Journal Article | Research Support, Non-U.S. Gov'tTreatment of experimental endocarditis due to methicillin-susceptible or methicillin-resistant Staphylococcus aureus with trimethoprim-sulfamethoxazole and antibiotics that inhibit cell wall synthesis.
- Journal Article | Research Support, Non-U.S. Gov'tTreatment of exogenous Candida endophthalmitis in rabbits with oral fluconazole.
- Journal ArticleIn vitro evaluation of ABT-719, a novel DNA gyrase inhibitor.
- Journal Article | Research Support, Non-U.S. Gov't | Research Support, U.S. Gov't, P.H.S.Use of 2'-fluoro-5-methyl-beta-L-arabinofuranosyluracil as a novel antiviral agent for hepatitis B virus and Epstein-Barr virus.
- Journal Article | Research Support, Non-U.S. Gov'tPneumococcal resistance in southwest Virginia.
- Comparative Study | Journal Article | Research Support, Non-U.S. Gov'tComparative in vitro activities of L-695,256, a novel carbapenem, against gram-positive bacteria.
- Journal Article | Research Support, Non-U.S. Gov'tTreatment of murine pulmonary blastomycosis with SCH 51048, a broad-spectrum triazole antifungal agent.
- Journal Article | Research Support, Non-U.S. Gov'tDifferential activities of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine derivatives against different human immunodeficiency virus type 1 mutant strains.
- Journal Article | Research Support, Non-U.S. Gov'tRibosylation by mycobacterial strains as a new mechanism of rifampin inactivation.
Letters
- Comment | LetterQuestionable susceptibility reporting in a multicenter trial.
- Comment | Letter | Research Support, Non-U.S. Gov'tGinkgo biloba extract EGb 761 is not active against Mycobacterium avium infection in C57BL/6 mice.